about
Effects of the physicochemical properties of gold nanostructures on cellular internalizationSmart functional nucleic acid chimeras: enabling tissue specific RNA targeting therapyDevelopment of a novel DNA aptamer ligand targeting to primary cultured tumor endothelial cells by a cell-based SELEX methodAS1411 aptamer tagged PLGA-lecithin-PEG nanoparticles for tumor cell targeting and drug delivery.Identification of tissue-specific targeting peptide.Aptamer-labeled PLGA nanoparticles for targeting cancer cells.Selective Delivery of an Anticancer Drug with Aptamer-Functionalized Liposomes to Breast Cancer Cells in Vitro and in Vivo.Applications of aptamers in nanodelivery systems in cancer, eye and inflammatory diseases.Unlocked nucleic acid--an RNA modification with broad potential.Synthetic approaches for the conjugation of porphyrins and related macrocycles to peptides and proteins.Targeted photodynamic therapy--a promising strategy of tumor treatment.Epithelial cell adhesion molecule-targeted drug delivery for cancer therapy.Aptamers: multifunctional molecules for biomedical research.Selecting Molecular Recognition. What Can Existing Aptamers Tell Us about Their Inherent Recognition Capabilities and Modes of Interaction?Vectors for the delivery of radiopharmaceuticals in cancer therapeutics.Receptor-targeted drug delivery: current perspective and challenges.Chimeric nucleolin aptamer with survivin DNAzyme for cancer cell targeted delivery.Tumor targeting with a (99m)Tc-labeled AS1411 aptamer in prostate tumor cells.Targeting cancer cells with controlled release nanocapsules based on a single aptamer.Targeted cell-cell interactions by DNA nanoscaffold-templated multivalent bispecific aptamers.Target binding influences permeability in aptamer-polyelectrolyte microcapsules.Targeted delivery of Epirubicin to cancer cells by PEGylated A10 aptamer.Aptamers as both drugs and drug-carriers.DNA Microcapsule for Photo-Triggered Drug Release Systems.MUC1 aptamer-conjugated mesoporous silica nanoparticles effectively target breast cancer cells.5TR1 aptamer-PEGylated liposomal doxorubicin enhances cellular uptake and suppresses tumour growth by targeting MUC1 on the surface of cancer cells.Current Conjugation Methods for Immunosensors.Virus-like particles: Next-generation nanoparticles for targeted therapeutic delivery.
P2860
Q26774279-0AFD3FB6-6B30-4C7B-9A54-8B6BF887ADD5Q27025832-BC77A2B5-1CB3-45F7-9316-123EE5477168Q28485460-55DB35EB-C263-464E-823C-A7222A2C437AQ34276778-E0F18384-5058-4EE1-AE00-2CF3BB40D912Q34458951-9A44F9F2-C9E1-4646-B52D-A7A03BB27E5BQ35673856-2674AB6F-C9D5-452F-A370-828868C332D1Q37240103-57D086F2-E632-4031-BE2E-FEDA2E2E34B2Q37815481-0B17F763-1F60-44E7-9EA0-AB2E1B0CF96CQ37856768-0130CA7F-7B46-46A1-9A1A-B66BFE4FC9A9Q37860172-F1B8DC18-2B2B-4D0C-8E93-7EFA70D0858CQ37872626-7990B617-C2C9-447F-AB66-413A871462E5Q38073792-39016F34-3B78-4A77-A972-AC74954F0424Q38138814-F9AFB7FF-5B1D-4FB2-B183-81A5B071B8D9Q38166624-F4E75CC4-4853-46EF-8C87-89EC04600D76Q38261959-3CF1AA75-038C-456F-90AA-04DB49C74040Q38265617-6FF0E6B1-0CE1-4932-87E9-9CC5DFCB044BQ38300295-CB733445-5B35-4173-8E55-7D509085DA06Q38301100-36D11442-217A-4596-B198-438F8C50D57AQ38318762-0383C321-5DA8-4890-A35C-3465C56CF01BQ38335450-B489C459-A0CF-48E9-92CB-5ECF346A4F50Q38335951-7C3ED2FF-043F-470F-939B-C838C93E22B2Q39132440-B5083ED8-33DD-4484-A121-A63099373052Q42236644-A255A52E-1B1B-4789-97C3-AE4068876D75Q47632277-2F848DE1-2661-4084-9241-E6C86EDEC265Q47918195-B2480EAF-3BE5-4072-82DF-1B5341A0CA17Q48581486-7F3B19FD-E8C3-4FB0-827A-45B68CDA8F9AQ52559226-7F3B44B5-3EEF-4FF3-BB6D-50502AB6344CQ54290026-9AE93790-CC25-4325-9192-A425377C4647
P2860
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Aptamers for Targeted Drug Delivery
@ast
Aptamers for Targeted Drug Delivery
@en
type
label
Aptamers for Targeted Drug Delivery
@ast
Aptamers for Targeted Drug Delivery
@en
prefLabel
Aptamers for Targeted Drug Delivery
@ast
Aptamers for Targeted Drug Delivery
@en
P2860
P356
P1433
P1476
Aptamers for Targeted Drug Delivery
@en
P2093
Rebekah R White
P2860
P304
P356
10.3390/PH3061761
P50
P577
2010-05-27T00:00:00Z